Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate
Abstract
No abstract availableKeywords
Funding Information
- Strategic Promotion of International Cooperation (JP24249024, JP26253026, JP26670202, JP15H05276, JP16K15266)
- Global Health Innovative Technology Fund (G2013-105)
This publication has 46 references indexed in Scilit:
- Can new treatment developments combat resistance in malaria?Expert Opinion on Pharmacotherapy, 2016
- Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaFEMS Microbiology Reviews, 2016
- Implementation of the malaria candidate vaccine RTS,S/AS01The Lancet, 2016
- Recent advances in recombinant protein-based malaria vaccinesVaccine, 2015
- Antibody titre as a surrogate of protection of the first malaria subunit vaccine, RTS,S/AS01The Lancet Infectious Diseases, 2015
- The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015Nature, 2015
- Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trialThe Lancet, 2015
- A Recombinant Blood‐Stage Malaria Vaccine ReducesPlasmodium falciparumDensity and Exerts Selective Pressure on Parasite Populations in a Phase 1–2b Trial in Papua New GuineaThe Journal of Infectious Diseases, 2002
- The pathogenic basis of malariaNature, 2002
- The effect of human immune IgG on the in vitro development of Plasmodium falciparumParasitology, 1976